SOC-1: Overall Survival Final Results with Drs. Rongyu Zang and Yulian Chen

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Rongyu Zang and Yulian Chen to discuss the SOC-1 trial. Dr. Rongyu Zang is the Director of the Department of Gynecologic Oncology, Fudan University Zhongshan Hospital, & Institute for Ovarian Cancer, Fudan University and is the Principal investigator of the SOC-1 and SUNNY trials. Dr. Yulian Chen is an Attending Physician at the Department of Gynecologic Oncology, Fudan University Zhongshan Hospital. Highlights: The SOC-1 trial concluded that in patients with platinum-sensitive, relapsed ovarian cancer, surgery did not increase overall survival in the intention-to-treat population, but resulted in a prolongation of survival after adjustment of crossover. Surgery may provide an obviously higher proportion of long-term relapse-free survivors than chemotherapy alone. An active preoperative evaluation for all patients with platinum-sensitive first relapsed ovarian cancer is suggested in specialized centers.

You can listen to SOC-1: Overall Survival Final Results with Drs. Rongyu Zang and Yulian Chen online on Radio and Podcast. Open the player on this page to stream the available audio.

SOC-1: Overall Survival Final Results with Drs. Rongyu Zang and Yulian Chen is an episode from IJGC Podcast by BMJ Group.

This episode is 32:24 long.

This episode was published on Oct 28, 2024.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from IJGC Podcast when more episodes are available from the podcast feed.